TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 57.20
0.00 (0.00%)
Jun 18, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 15.63 billion as of June 18, 2026. Its market cap has decreased by -27.30% in one year.
Market Cap
15.63B
Enterprise Value
14.48B
Revenue
601.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.20
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 15.63B, an increase of 505.60%. That is a compound annual growth rate of 11.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 15.63B | -6.54% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.94B |
| Sunmax Biotechnology | 20.42B |
| Lumosa Therapeutics | 17.75B |
| Medigen Vaccine Biologics | 14.93B |
| CHO Pharma | 14.34B |
| EirGenix | 13.62B |
| Ever Supreme Bio Technology | 12.74B |
| Polaris Group | 11.35B |